FacebookTwitterGoogle+RedditEmail

The Drug Industry Takes Another Hit

If Hillary and Obama think the press is picking on them, they should look at Big Pharma.

The ink isn’t even dry on the massive Vioxx settlement and already Big Pharma’s been accused of burying clinical data, spinning journal articles and selling drugs that cause the conditions they’re supposed to fix. Sound familiar?

Merck and Schering-Plough, it turns out, were sitting on the ENHANCE clinical trial results of cholesterol lowering drug, Vytorin for a reason. Rather than reducing the growth of fatty plaque in the arteries, Vytorin, a combination of Zetia and Zocor, almost doubled the growth in the trials.

Not only did it take a Congressional committee to pry the truth out of the Big Pharma giants, their response to the clinical belly flop was that they “would be changing the ENHANCE study’s endpoint”–the actual result the study was meant to measure. In other words, the sun was in their eyes.

Nor was it just TV that Big Pharma is accused of using in service to half truths like “Vytorin treats cholesterol from two sources: food and family.”

Ninety-four percent of positive studies about antidepressants found their way into medical journals versus 14 percent of negative ones says an article in the January 17, 2008 issue of the New England Journal of Medicine called Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy.
Publishing only pro drug articles deprives researchers of accurate data, wastes resources, squanders the contributions of investigators and patients and misleads doctors says lead author Erick Turner, an assistant professor of psychiatry at Oregon Health and Science University.

New bone medications also took a hit in a medical literature analysis in 2008.

After screening 1,825 published papers from 1966 to 2007, researchers found no evidence that bisphosphonates such as Fosamax or Actonel are superior to older bone drugs in Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis in the February 8 issue of Annals of Internal Medicine. They did find the newer drugs can have serious side effects such as strokes, blood clots in the lungs or bleeding in the uterus (a January 15, 2008 Journal of Rheumatology paper finds oral bisphosphonate drugs nearly triple the risk of developing bone necrosis) and that “data are insufficient to determine the relative efficacy or safety” of all the studied drugs.

Some will notice the antidepressant article in the New England Journal of Medicine and bone drug article in the Annals of Internal Medicine are unusually short. They lack the obligatory six inches of drug company financial support to the researchers which most journal articles show at the end. (In a pro Cox-2 inhibitor article in the December 22, 2007 issue of Lancet author Vibeke Strand lists 49 drug companies she’s received money from. Who even knew there were 49 drug companies?)

Thanks to the Vioxx, HRT and Avandia scandals, the public is no longer shocked to learn that Big Pharma hides side effects like heart attacks or sells drugs that actually cause the conditions they are supposed to alleviate like antidepressants and suicide or bisphosphonates and fractures.

But disease mongering still seems a violation of First Do No Harm.

In January thousands of Northwestern students found a “Kick Crohn’s Back” brochure in their daily newspaper replete with checklist–Does abnormal pain or other Crohn’s symptoms force you to miss school, work or events with friends or family?– and photo of glowing young couple “going out to dinner and actually eating dinner.”

What percentage of 19-years-olds gets Crohn’s disease to justify use of Humira whose side effects include lethal infections and cancer? Or is the insert meant for the set of all 19-year-olds with rheumatoid arthritis and psoriatic arthritis, the other diseases Humira treats?

And then there’s fibromyalgia, another amorphous, no cause/no cure/no clear definition condition that lends itself to lucrative direct-to-consumer self-diagnosis .

Pfizer spent $40 million advertising Lyrica, approved for fibromyalgia in June, in 2007 buttressed by free PSAs from the National Fibromyalgia Association (NFA) which directed people to a web site with the Pfizer logo and phone number.
This “unbranded,” “condition-awareness” marketing as it’s called in the industry, sponsored by Pfizer but funneled through the NFA helped Lyrica post 118,871 new and 203,737 total prescriptions in December noted Bear Stearns analyst John Boris saying he was impressed with the data points’ upward trajectory.

But it also moved the New York Times to ask on its front page in January “Drug Approved. Is Disease Real?”

And even if the disease is real and not another self fulfilling prophesy, Big Pharma will no doubt find itself back in court with suits over fibro drugs’ Zyprexa-like weight gain side effects which start early in therapy with gains of as much as seven percent that do not taper off.

Yes, thanks to a bad start in 2008 Pharma has a lot of “negatives” to overcome. But unlike the presidential candidates, its troubles won’t end in eleven months. They may even get worse.

MARTHA ROSENBERG is staff cartoonist on the Evanston Roundtable. She can be reached at mrosenberg@evmark.org

 

 

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

September 25, 2018
Kenneth Surin
Fact-Finding Labour’s “Anti-Semitism” Crisis
Charles Pierson
Destroying Yemen as Humanely as Possible
James Rothenberg
Why Not Socialism?
Patrick Cockburn
How Putin Came Out on Top in Syria
John Grant
“Awesome Uncontrollable Male Passion” Meets Its Match
Guy Horton
Burma: Complicity With Evil?
Steve Stallone
Jujitsu Comms
William Blum
Bombing Libya: the Origins of Europe’s Immigration Crisis
John Feffer
There’s a New Crash Coming
Martha Pskowski
“The Emergency Isn’t Over”: the Homeless Commemorate a Year Since the Mexico City Earthquake
Fred Baumgarten
Ten Ways of Looking at Civility
Dean Baker
The Great Financial Crisis: Bernanke and the Bubble
Binoy Kampmark
Parasitic and Irrelevant: The University Vice Chancellor
September 24, 2018
Jonathan Cook
Hiding in Plain Sight: Why We Cannot See the System Destroying Us
Gary Leupp
All the Good News (Ignored by the Trump-Obsessed Media)
Robert Fisk
I Don’t See How a Palestinian State Can Ever Happen
Barry Brown
Pot as Political Speech
Lara Merling
Puerto Rico’s Colonial Legacy and Its Continuing Economic Troubles
Patrick Cockburn
Iraq’s Prime Ministers Come and Go, But the Stalemate Remains
William Blum
The New Iraq WMD: Russian Interference in US Elections
Julian Vigo
The UK’s Snoopers’ Charter Has Been Dealt a Serious Blow
Joseph Matten
Why Did Global Economic Performance Deteriorate in the 1970s?
Zhivko Illeieff
The Millennial Label: Distinguishing Facts from Fiction
Thomas Hon Wing Polin – Gerry Brown
Xinjiang : The New Great Game
Binoy Kampmark
Casting Kavanaugh: The Trump Supreme Court Drama
Max Wilbert
Blue Angels: the Naked Face of Empire
Weekend Edition
September 21, 2018
Friday - Sunday
Alexandra Isfahani-Hammond
Hurricane Florence and 9.7 Million Pigs
Andrew Levine
Israel’s Anti-Semitism Smear Campaign
Paul Street
Laquan McDonald is Being Tried for His Own Racist Murder
Brad Evans
What Does It Mean to Celebrate International Peace Day?
Nick Pemberton
With or Without Kavanaugh, The United States Is Anti-Choice
Jim Kavanagh
“Taxpayer Money” Threatens Medicare-for-All (And Every Other Social Program)
Jonathan Cook
Palestine: The Testbed for Trump’s Plan to Tear up the Rules-Based International Order
Jeffrey St. Clair
Roaming Charges: the Chickenhawks Have Finally Come Back Home to Roost!
David Rosen
As the Capitalist World Turns: From Empire to Imperialism to Globalization?
Jonah Raskin
Green Capitalism Rears Its Head at Global Climate Action Summit
James Munson
On Climate, the Centrists are the Deplorables
Robert Hunziker
Is Paris 2015 Already Underwater?
Arshad Khan
Will There Ever be Justice for Rohingya Muslims?
Jill Richardson
Why Women Don’t Report Sexual Assault
Dave Clennon
A Victory for Historical Accuracy and the Peace Movement: Not One Emmy for Ken Burns and “The Vietnam War”
W. T. Whitney
US Harasses Cuba Amid Mysterious Circumstances
Nathan Kalman-Lamb
Things That Make Sports Fans Uncomfortable
George Capaccio
Iran: “Snapping Back” Sanctions and the Threat of War
Kenneth Surin
Brexit is Coming, But Which Will It Be?
FacebookTwitterGoogle+RedditEmail